C 1      Klein DF.  (1964)  Behavioral effects of imipramine and phenothiazines:  implications for a psychiatric pathogenic theory and theory of drug action.  In:  Joseph Wortis (Ed).  Recent Advances in Biological Psychiatry, Volume VII.  New York:  Plenum Press.  pp 273-287. C 2      Klein DF.  (1968)  Diagnosis and pattern of reaction to drug treatment:  clinically derived formulations.  In:  Katz NM, Cole JO, Barton WE (Eds).  The Role and Methodology of Classification in Psychiatry and Psychopathology.   NIMH.  pp 466-483. C 3      Gittelman-Klein R & Klein DF.  (1968)  Long-term effects of antipsychotic agents:  a review.  In:  Efron DH (Ed).  Psychopharmacology: a review of progress, 1957-1967.  Washington, DC:  Government Printing Office.  pp 1119-1153. C 4     Klein DF, Honigfeld G, Feldman S.  (1969)  Prediction of drug effect by a successivescreening decision tree diagnostic technique.  In:  May PRD & Wittenborn JR (Eds).  Psychotropic drug responses:  advances in prediction.  Charles C. Thomas.  pp 45-91. C 5      Klein DF.  (1969)  Psychopharmacological treatment of bereavement and its complications.  In:  Kutscher AH (Ed).  Death and Bereavement.  Charles C. Thomas.  pp 299-304. C 6     Woerner MG, Pollack M, Rogalski C, Pollack Y, Klein DF.  (1970)  A comparison of childhood characteristics of schizophrenics, personality disorders and their siblings.  In: Roff M & Ricks D (Eds).  Life History Research in Psychopathology.  :  Univ. of Minnesota Press.  pp 208-225. C 7     Klein DF, Feldman S, Honigfeld G.  (1970)  Can univariate measures of drug effect reflect clinical descriptions of change?  In: Wittenborn JR, Goldberg SC, May PRA (Eds).  Psychopharmacology and the Individual Patient.   New York:  Raven Press.  pp 189-225. C 8     Klein DF.  (1970)  The importance of diagnosis:  an analysis and program.  In:  Rothman T (Ed).  Changing Patterns in Psychiatric Care.  :  Crown Publications.  pp 229-244. C 9     Rosen B, Levenstein S, Shahinian SP, Klein DF.  (1970)  Social competence and posthospital outcome.  In:  Rothman T (Ed).  Changing Patterns in Psychiatric Care.  :  Crown Publications.  pp 245-255. C 10    Klein DF.  (1970)  Psychotropic drugs and the regulation of behavioral activation in psychiatric illness.  In:  Smith WL (Ed).  Drugs and Cerebral Function.  :  Charles C. Thomas.  pp 69-81. C 11   Klein DF.  (1970)  Constraints on psychiatric treatment research produced by the organization of clinical services.  In:  Merlis S (Ed).  Non-Scientific Constraints on Medical Research.  New York:  Raven Press.  pp 69-90. C 12   Klein DF.  (1971)  Approaches to measuring the efficacy of drug treatment of personality disorders:  An analysis and program.  In:  Principles and Problems in Establishing the Efficacy of Psychotropic Agents.  US Dept. of Health, Education & Welfare, Public Health Service, #2138.  pp 187-204. C 13   Gittelman-Klein R, Klein DF.  (1972)  School phobia:  Diagnostic considerations in the light of imipramine effects.  In:  Smith L (Ed).  Drugs, Development and Cerebral Function.  Charles C. Thomas.  pp 200-223. C 14   Quitkin F, Rifkin A, Klein DF.  (1972)  Lithium in other psychiatric disorders.  In:  Gershon S, Shopsin B (Eds).  Lithium: Its Role in Psychiatric Research and Treatment.  Plenum Press.  pp 295-315. C 15   Klein DF.  (1973)  Methodology for study of bereavement.  In: Goldberg IK, Malitz S, Kutscher AH (Eds).  Psychopharmacological Agents for the Terminally Ill and Bereaved.  Columbia University Press.  pp 318-319. C 16   Klein DF.  (1973)  Drug therapy as a means of syndromal identification and nosological revision.  In:  Cole JO, Freedman AM, Friedhoff AJ (Eds).  Psychopathology and Psychopharmacology.  The Johns Hopkins Press.  pp 143-160. C 17   Klein DF, Honigfeld G, Feldman S.  (1972)  Prediction of drug effect in personality disorders.  In:  Smith L (Ed).  Drugs, Development and Cerebral Function.  Charles C. Thomas.  pp 248-269. C 18   Klein DF, Gittelman-Klein R.  (1974)  Diagnosis of minimal brain dysfunction and hyperkinetic syndrome.  In:  Conners K (Ed).  Clinical Use of Stimulant Drugs in Children.  The Hague:  Excerpta Medica.  pp 1-10. C 19   Klein DF.  (1974)  Who should not be treated with neuroleptics, but often are?  In:  Ayd F (Ed).  Rational Psychopharmacotherapy and the Right to Treatment.  Ayd Medical Communications, Ltd.  pp 29-36. C 20   Klein DF.  (1974)  Endogenomorphic depression.  In:  Angst J (Ed).  Classification and Prediction of Outcome of Depression.  Symposia Medica Hoechst.  Stuttgart:  Schattauer Verlag.  pp 289-300. C 21   Honigfeld G, Klein DF.  (1975)  Computerized translatable psychiatric history form.  In:  Turan I (Ed).  Transcultural Neuropsychopharmacology.  Istanbul:  M. Bozak Publications. C 22   Klein DF.  (1975)  Psychopharmacology and the borderline patients.  In:  Mack JG (Ed).   Borderline State in Psychiatry.  Gruen & Stratton, Inc.  pp 75-91. C 23   Rifkin A, Quitkin F, Klein DF.  (1975)  Longterm use of antipsychotic drugs.  In:  Klein DF, Gittelman-Klein R (Eds).  Progress in Psychiatric Drug Treatment.   New York City:  Brunner/Mazel.  pp 387-396. C 24   Quitkin F, Rifkin A, Klein DF.  (1975)  Prophylaxis of affective disorders: A review.  In:   Klein DF, Gittelman-Klein R (Eds).  Progress in Psychiatric Drug Treatment.  New York City:  Brunner/Mazel.  pp 226-279. C 25   Klein DF.  (1975)  Differential diagnosis and treatment of the dysphorias.  In:  Simpson GM, Gallant DM (Eds).  Depression: Behavioral, Biochemical, Clinical and Treatment Concepts.   Spectrum Press.  pp 127-154. C 26   Schildkraut JJ, Klein DF.  (1975)  The classification and treatment of depressive disorders.  In:  Shader RI (Ed).  Manual of Psychiatric Therapeutics:  Practical Psychopharmacology & Psychiatry.  Little Brown & Company.  pp 39-61. C 27   Klein DF.  (1975)  Treating anxiety.  In:   Anxiety: Decision at  the Synapse.  New York:  Medcom.  pp 31-33. C 28   Klein DF.  (1975)  Clinical phenomena of anxiety.  In:  ]   Anxiety:  Decision at the Synapse.  New York:  Medcom.  pp 10-13. C 29   Klein DF, Shader RI.  (1975)  The borderline state:  Psychopharmacologic treatment approaches to the undiagnosed case.  In:  Shader RI (Ed).  Manual of Psychiatric Therapeutics: Practical Psychopharmacology in Psychiatry.  Little Brown & Co.  pp 281-293.   Also in:  Shagass C (Ed).   (1977)  Psychopathology and Brain Dysfunction.  New York:  Raven Press.  pp. 199-221. C 30    Kane J, Rifkin A, Quitkin F, Klein DF.  (1976)  Antidepressant drug blood levels, pharmacokinetics and clinical outcome.  In:  Klein DF, Gittelman-Klein R (Eds).   Progress in Psychiatric Drug Treatment, Volume 2.  New York City:  Brunner/Mazel.  pp 136-158. C 31    Rifkin A, Quitkin F, Kane J, Klein DF.  (1976)  Longterm use of antipsychotic drugs.  In:  Klein DF, Gittelman-Klein R (Eds).  Progress in Psychiatric Drug Treatment II.  New York City:  Brunner/Mazel.  pp 322-329. C 32    Zitrin CM, Klein DF, Lindemann C, Toback P, Rock M, Kaplan JH, Ganz VH.  (1976)  Comparison of short-term treatment regimens in phobic patients.  In:  Spitzer RL, Klein DF (Eds).  Evaluation of Psychological Therapies.  The Johns Hopkins Press.  pp 233-250. C 33    Klein DF.  (1976)  Diagnosis of anxiety and differential use of anti-anxiety drugs.  In:  Simpson L (Ed).  Drug Treatment of Mental Disorders.  New York:  Raven Press.  pp 61-72. C 34    Kane J, Rifkin A, Quitkin F, Klein DF.  (1976)  Antipsychotic drug blood levels and clinical outcome.  In:  Klein DF, Gittelman-Klein R (Eds).  Progress in Psychiatric Drug Treatment II.  New York City:  Brunner/Mazel. pp 399-408. C 35    Quitkin F, Rifkin A, Kane J, Klein DF.  (1976)  Amine biochemistry and treatment of depression.  In:  Klein DF, Gittelman-Klein R (Eds).  Progress in Psychiatric Drug Treatment II.  New York City:  :  Brunner/Mazel.  pp 79-86. C 36    Klein DF.  (1977)  Psychotropic drugs and the pregnant patient.  In:  Rovinsky J (Ed).   Medical, Surgical, & Gynecological Complications of Pregnancy.  Williams & Wilkins. C 37    Klein DF.  (1977)  Psychopharmacological treatment and delineation of borderline disorders.  In:  Hartocollis P (Ed).  Borderline Personality Disorders: The Concept, the Syndrome, the Patient.  International Universities Press, Inc.  pp 365-383. C 38    Struve FA, Saraf KR, Arko RS, Klein DF, Becka R.  (1977)  Relationship between paroxysmal electroencephalographic dysrhythmia and suicide ideation and attempts in psychiatric patients.  In:  Gershon S, Shagass C (Eds).  Psychopathology and Brain Dysfunction.  New York:  Raven Press.  pp 199-221. C 39    Klein DF.  (1978)  A proposed definition of mental illness.  In:  Spitzer R, Klein DF (Eds).  Critical Issues in Psychiatric Diagnosis.  New York:  Raven Press.  pp 41-71. C 40    Klein DF, Gittelman-Klein R.  (1978)  Drug treatment of separation anxious and depressive illness in children. In:  Mendlewicz J (Ed).  Advances in Biological Psychiatry.  Basel:  Karger. C 41    Klein DF, Zitrin CM, Woerner M.  (1978)  Antidepressants, anxiety, panic and phobia.  In:  Lipton MA, DiMascio A, Killman K (Eds).  Psychopharmacology:  A Generation of Progress.  New York:  Raven Press.  pp 1401-1410. C 42    Klein DF.  (1978)  The pharmacotherapy of anxious and phobic states.  In:  Levine J (Ed).  Contemporary Standards for the Pharmacotherapy of Mental Disorders, Vol. XII.  Mt. Kisco, NY:  Futura Publishing Co.  pp 185-204. C 43    Klein DF.  (1979)  General discussion.  In:  Bellak L (Ed).  Psychiatric Aspects of Minimal Brain Dysfunction in Adults.  Grune & Stratton, Inc.   pp 151-157. C 44    Klein DF.  (1980)  Discussion:  Clinical and biological aspects of depression in the elderly.  In:  Cole JO, Barrett JE (Eds).  Psychopathology in the Aged.  Proceedings of 1979 APPA Meeting.  New York:  Raven Press.  pp 197-203. C 45    Gittelman-Klein R, Abikoff H, Pollack E, Klein DF, Katz S, Mattes.  (1980)  A controlled trial of behavior modification and methylphenidate in hyperactive children.  In:  Whalen C, Henker B (Eds).  Hyperactive Children:  The Social Ecology of Identification and Treatment.  Academic Press.  pp 221-243. C 46    Gittelman R, Klein DF.  (1980)  Separation anxiety in school refusal and its treatment with drugs.  In:  Hersov L (Ed).  Out of School.  John Wiley & Sons.  pp 321-341. C 47    Klein DF.  (1981)  Anxiety reconceptualized; Gleaning from pharmacological dissection–early experience with imipramine and anxiety.  In:  Klein DF, Rabkin JG (Eds).  Anxiety: New Research & Changing Concepts.  New York:  Raven Press.  pp 235-262.  Also in:   Ban TA, Pichot P, Poldinger W (Series eds); Klein DF (Volume ed).  Modern Problems of Pharmacopsychiatry, Volume 22:  Anxiety.  (1987)  Basel:  Karger.  pp 1-35. C 48    Zitrin CM, Woerner MG, Klein DF.  (1981)  Differentiation of panic anxiety from anticipatory anxiety and avoidance behavior.  In:  Klein DF, Rabkin JG (Eds).  Anxiety: New Research & Changing Concepts.  New York:  Raven Press.  pp 27-46. C 49    Gorman JM, Fyer AF, Gliklich J, King DL, Klein DF.  (1981)  Mitral valve prolapse and panic disorders:  Effects of imipramine.  In:  Klein DF, Rabkin JG (Eds).  Anxiety:  New Research & Changing Concepts.  New York:  Raven Press.  pp 317-326. C 50    Appleby IL, Klein DF, Sachar EJ, Levitt M.  (1981)  Biochemical indices of lactate-induced panic:  A preliminary report.  In:  Klein DF, Rabkin JG (Eds).  Anxiety: New Research and Changing Concepts.  New York:  Raven Press.  pp 411-423. C 51    Liebowitz MR, Klein DF.  (1981)  Differential diagnosis and treatment of panic attacks and phobic states.  In:  Creger WP, Coggins CH, Hancock EW (Eds).  Annual Review of Medicine: Selected Topics in the Clinical Sciences, Vol. 32.   pp 583-599. C 52    Dillon DJ, Levitt M, Klein DF, Danielson E.  (1981)  Some physiological, biochemical and psychological concomitants of lactate induced panic:  A preliminary report.  In: Neuropsychology & Cognition, Vol. II.  Alphen, [?] Aan den Rijn, The Netherlands:  Sijthoff & Noordhoff Intl. Publications.  pp 651-660. C 53    Strain JJ, Liebowitz MR, Klein DF.  (1981)  Anxiety and panic attacks in the medically ill.  In: Strain JJ (Ed).  The Medical1y Ill Patient.  Philadelphia, PA:  Saunders. C 54    Liebowitz MR, Klein DF.  (1981)  Uses of MAO inhibitors for borderline patients.  In:  Friedel RO (Ed).  The Borderline Patient: Diagnosis and Treatment.  Proceedings of the 1980 Annual Meeting of the APA.  San Francisco, CA.   pp 22-28. C 55    Liebowitz MR, Klein DF.  (1982)  Agoraphobia:  Clinical features, pathophysiology & treatment.  In:  Chambless DL, Goldstein A (Eds).  Agoraphobia: Contextual Analysis and Treatment.  John Wiley & Sons.  pp 153-181. C 56    Klein DF, Liebowitz MR.  (1982)  Psychotherapeutic attitudes in the drug treatment of anxiety and phobic reactions.  In:  Greenhill [?], Gralnick A (Eds).  Psychopharmacology and Psychotherapy.  The Free Press.  pp 145-163. C 57    Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison W, Karoum F, Wyatt R, Levitt M, Rabkin J, Klein DF.  (1982)  Efficacy of deprenyl in atypical depression: A preliminary report.  Symposium on Deprenyl.  Hungary. C 58    Quitkin FM, Schwartz D, Liebowitz MR, Stewart JR, McGrath PJ, Harrison W, Halpern F, Puig-Antich K, Tricamo E, Sachar EJ, Klein DF.  (1982)  Atypical depressives:  A preliminary report of antidepressant response, sleep patterns, and cortisol secretion.  In:  Clayton PJ, Barrett JE (Eds).  Treatment of Depression:  Old Controversies and New Approaches.  New York:  Raven Press.  pp 253-263. C 59    Klein DF.  (1982)  Psychopharmacology:  Special considerations.  In:  Pepper B, Ryglewicz H (Eds).  New Directions for Mental Health Services: The Young Adult Chronic Patient, No. 14.  San Francisco:  Jossey-Bass. C 60    Rabkin JG, Klein DF.  (1982)  The biological therapies.  In:  Lewis J, Usdin G (Eds).  Treatment Planning in Psychiatry.  Washington, DC: American Psychiatric Association.  pp 87 C 61    Potter WZ, Agren H, Carlsson A, Cowdry RW, Delini-Stula A, Emrich HM, Herz A, Kehr W, Klein DF, Maj J, Svensson TH.  (1983)  Neurotransmission.  In:  Angst J (Ed).  The Origins of Depression: Current Concepts and Approaches.  Berlin, GY:  Dahlem Konferenzen.  New York City:  Springer-Verlag.  pp 447-457. C 62    Klein D.  (1983)  A personal view of psychopharmacology for non-psychotic adolescents. In:  Golombek H, Garfinkel BD (Eds).  The Adolescent and Mood Disturbance.    International Universities Press.  pp 239-247. C 63    McGrath PJ, Klein DF.  (1983)  Heuristically important mood altering drugs.  In:  Angst J (Ed).  The Origins of Depression: Current Concepts and Approaches.  Berlin, GY:  Dahlem Konferenzen.  New York City:  Springer-Verlag.  pp 331-349. C 64    Rabkin JG, Klein DF, Quitkin FM.  (1983)  Somatic treatment of acute depression.  In:  Rifkin A (Ed).  Schizophrenia & Affective Disorders.  Littleton, MA:  Wright-PSJ, Inc.  pp 35-78. C 65    Klein DF.  (1983)  Critique.  In:  Cooper JR, Altman F, Brown BS, Czechowicz D (Eds)  Research on the Treatment of Narcotic Addiction:  State of the Art.   Natl. Inst. of Drug Abuse.  pp 149-157. C 66    Quitkin FM, Klein DF.  (1983)  Effectiveness of monoamine oxidase inhibitors:  A review.  In:  Habig RL (Ed).  The Brain, Biochemistry and Behavior.  Proceedings of the Sixth Arnold O. Beckman Conference in Clinical Chemistry, Washington, DC.  Tarpon Springs, FL:  The American Association for Clinical Chemistry.  pp 125-169. C 67    Quitkin FM, Schwartz D, Liebowitz MR, Stewart JR, McGrath PJ, Harrison W, Halpern F, Puig-Antich J, Tricamo E, Sachar EJ, Klein DF.  (1983)  Atypical depressives:  A preliminary report of antidepressant response, sleep patterns and cortisol secretion.  In:  Clayton PJ, Barrett JE (Eds).  Treatment of Depression: Old Controversies and New Approaches.  New York:  Raven Press.  pp 253-263. C 68    Rabkin JG, Klein DF, Quitkin FM.  (1983)  Somatic treatment of acute depression.  In:  Rifkin A (Ed).  Biology and Drug Treatment of Schizophrenia and Affective Disorders.  New York City:  Wright-PSG.  pp 35-78. C 69    Liebowitz MR, Klein DF, Quitkin FM, Stewart JW, McGrath PJ.  (1983)  Clinical implications of diagnostic subtypes of depression.  In:  Post RM, Ballenger JC (Eds).  Neurobiology of Mood Disorders, Vol. 1.  Williams & Wilkins.  pp 107-120. C 70    Klein DF, Rabkin JG.  (1984)  Specificity and strategy in psychotherapy research and practice.  In:  Williams J, Spitzer R (Eds).  Psychotherapy Research: Where are We and Where Should We Go?  New York City:  The Guilford Press.  pp 306-331. C 71    Levin AP, Liebowitz MR, Fyer AJ, Gorman JM, Klein DF.  (1984)  Lactate induction of panic:  Hypothesized mechanisms and recent findings.  In:   Biology of Agoraphobia.   APA Monograph.  pp 81-97. C 72    Klein DF.  (1984)  Introduction to the Anxiety Disorders Program.  In: Grinspoon, L (Ed).  Psychiatry Update American Psychiatric Association Annual Review, Vol 3.  Washington, DC:  American Psychiatric Press, Inc.  pp 390-392. C 73    Klein DF.  (1984)  Unresolved questions.  In: Grinspoon L (Ed).  American Psychiatric Annual Review, Vol 3:  Psychiatry Update.  Washington, DC:  American Psychiatric Press, Inc.  pp 519-525. C 74    Liebowitz MR, Karoum F, Quitkin FM, Stewart J, McGrath PJ, Harrison W, Davies SO, Klein DF.  (1984)  Biochemical effects and antidepressant mechanisms of l-deprenyl.  In: Boulton AA, Baker GB, Dewhurst WG, Sandler M (Eds).  Neurobiology of Trace Amines.  Clifton, NJ:  Humana Press.  pp 581-587. C 75    Klein DF.  (1985)  Boundaries between DSM-III, anxiety and affective disorders.  In:  Cassano GB (Ed).   Il DSM-III in Italia, Diagnose e Classificazione dei Disturbi Affettivi.   Proceedings of the DSM-III Meeting; Florence, Italy, November, 1983:  Xanax Cross National Collaborative Panic Studies Training Workshop.  :  Masson Italia Editori.  pp 51-55. C 76    Fyer A, Klein DF.  (1985)  Agoraphobia, social phobia, and simple phobia.  In:  Kavenar JO (Ed).  Psychiatry, Vol. 1.  Philadelphia, PA:  JB Lippincott.  pp 1-14. C 77    Klein DF, Rabkin J, Gorman JM.  (1985)  Etiological and pathophysiological inferences from the pharmacological treatment of anxiety.  In:  Maser JD, Tuma AA (Eds).  Anxiety and the Anxiety Disorders.  Hillsdale, NJ:  Erlbaum Publishing.  pp 501-532. C 78    Rabkin JG, Stewart J, Klein DF.  (1985)  Overview on the relevance of the Dexamethasone Suppression Test to differential diagnosis.  In:  Hirschfeld RMA, Koslow SH, Kupfer DJ (Eds).  Clinical Utility of the Dexamethasone Suppression Test.  Rockville, MD:  U.S. Department of Health & Human Services. C 79    Liebowitz MR, Fyer AJ, Gorman JM, Campeas R, Levin A, Davies SO, Klein DF.  (1985)  Alprazolam in the treatment of panic disorders.  In:  Lader MH, Davies HC (Eds).  Drug Treatment of Neurotic Disorders:  Focus on Alprazolam.   Churchill Livingston.  pp 173-177. C 80    Gittelman R, Klein DF.  (1985)  Childhood separation anxiety and adult agoraphobia.  In:  Tuma AH, Maser JD (Eds).  Anxiety and the Anxiety Disorders.   Lawrence Erlbaum Assoc., Inc.  pp 389-411. C 81    Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison W, Rabkin J, Tricamo E, Markowitz JS, Klein DF.  (1986)  Treatment of atypical depression: Phenelzine, imipramine and placebo.  In:  Hippius H, Klerman G, Matussek N (Eds).  New Results in Depression Research.  Heidelberg, GY:  Springer-Verlag.  pp 112-117. C 82    Rabkin JG, Klein DF.  (1987)  The clinical measurement of depressive disorders.  In:  Marsella A, Hirschfeld R, Katz M (Eds).  The Measurement of Depression.  New York City:  Guilford Press.  pp 30-83. C 83    Klein DF.  (1987)  Depression and Anhedonia.  In:  Clark DC, Fawcett J (Eds).  Anhedonia and Affect Deficit States.  New York City:  PMA Publishing Corp. C 84    Klein DF.  (1987)  Sexual disorders and medication.  In:  Kaplan-Singer H (Ed).  Sexual Aversion, Sexual Phobias, and Panic Disorder.  New York City:  Brunner/Mazel, Inc. C 85    Nunes EV, Klein DF.  (1987)  Research issues in cocaine abuse:  Future directions.  In: Spitz HI, Rosecan JS (Eds).  Cocaine Abuse: New Directions in Treatment Research.  New York City:  Brunner/Mazel. C 86    Gorman JM, Fyer A, Liebowitz MR, Klein DF.  (1987)  Pharmacologic provocation of panic attacks.  In:  HY Meltzer (Ed).  The Third Generation of Progress.   New York:  Raven Press.  pp 985-993. C 87    Klein RG, Klein DF.  (1988)  Adult anxiety disorders and childhood separation anxiety.  In:  Roth M, Noyes R Jr., Burrows GD (Eds).  Handbook of Anxiety, Volume 1: Biological Clinical and Cultural Perspectives.  Amsterdam:  Elsevier Science Publishers.   pp 213-229. C 88    Cooper TB, Harrison WM, Stewart JW, Klein DF.  (1988)  Decreased tyramine conjugation in melancholia:  A trait marker.  In:  Boulton AA, Juorio AV, Downer RGH (Eds).  Trace Amines:  Comparative and Clinical Neurobiology.  Clifton, NJ:  Humana Press, Inc.  pp 379-386. C 89    Hollander E, Fay M, Klein DF, Liebowitz MR.  (1988)  Catecholaminergic and monoaminergic effects in obsessive-compulsive disorder.  In:  Belmaker RH, Sandler M, Dahlstrom A (Eds).  Progress in Catecholamine Research, Part C: Clinical Aspects.  New York City:  Alan R. Liss, Inc.  pp 377-383. C 90    Klein DF, Klein HM.  (1989)  The definition and psychopharmacology of spontaneous panic and phobia: A critical review I.  In:  Tyrer PJ (Ed).  Psychopharmacology of Anxiety.  New York City:  Oxford University Press.  pp 135-162. C 91    Klein DF, Klein HM.  (1989)  The nosology, genetics and theory of spontaneous panic and phobia:  A critical review II.  In:  Tyrer PJ (Ed).  Psychopharmacology of Anxiety.  New York City:  Oxford University Press.  pp 163-195. C 92    Hollander E, Klein DF.  (1989)  Medication.  In:  Lindemann C (Ed).  Handbook of Phobia Therapy:  Rapid Symptom Relief in Anxiety Disorders.   Northvale, NJ:  Jason Aronson, Inc.  pp 405-425. C 93    Klein DF.  (1989)  The pharmacological validation of psychiatric diagnosis.  In:  Robbins LN, Barrett J (Eds).  Validity of Psychiatric Diagnosis.  New York:  Raven Press, Ltd.  pp 203-216. C 94    Hollander E, Klein DF.  (1989)  Differential diagnosis of anxiety disorders.  In:  Kielholz P, Adams C (Eds).  Panic Anxiety States.  Koln:  Deutscher Arzte-Verlag.  pp 17-26.  Also in:  Kielholz P, Adams C (Eds).  The Kaleidoscope of Anxiety (German version:  Die Vielfalt von Angstzustanden).  Koln:  Deutscher Arzte-Verlag.  pp 150-159. C 95    Hollander E, Hatterer J, Klein DF.  (1990)  Antidepressants for the treatment of panic and agoraphobia.  In:  Noyes R, Roth M, Burrows GD (Eds).  Handbook of Anxiety Disorders, Vol. 4: The Treatment of Anxiety.  Amsterdam:  Elsevier Science Publishers.  pp 207-232. C 96    Fyer AJ, Liebowitz MR, Klein DF.  (1990)  Treatment trials, comorbidity, and syndromal complexity.  In:  Maser JD, Cloniger CR (Eds).  Comorbidity of Anxiety and Depression.   Washington, DC:  American Psychiatric Press.  pp 669-679. C 97    Klein DF, Klein HM.  (1990)  Clinical validation of anxiety syndromes.  In:  Sartorius N (Ed).  Anxiety: Psychobiological and Clinical Perspectives.  Washington, DC:  Hemisphere Publishing Corporation. C 98    Gorman JM, Papp L, Klein DF.  (1990)  Biological models of panic disorder.  In:  Burrows GD, Roth M, Noyes R Jr. (Eds).  Handbook of Anxiety, Vol. 3:  The Neurobiology of Anxiety.  Amsterdam:  Elsevier Science Publishers, B.V. ; and New York City:  Oxford University Press. C 99    Klein DF, Coplan JD, Gorman JM.  (1991)  Bases for serotonin related drug use in spontaneous panic behaviour.  In:  Cassano GB, Akiskal HS (Eds).  Serotonin-Related Psychiatric Syndromes:  Clinical and Therapeutic Links.  International Congress and Symposium of the Royal Society of Medicine Services, Series No. 165.  London, UK:  Royal Society of Medicine Services Limited.  pp 93-97. C 100  Fyer AJ, Sandberg D, Klein DF.  (1991)  Pharmacological treatment of panic disorder and agoraphobia.  In:  Walker JR, Norton R, Ross C (Eds).  Panic Disorder and Agoraphobia: A Guide for the Practitioner.  Pacific Grove, CA:  Brooks/Cole Publishing Co.  pp 211-251. C 101  Stewart JW, Rabkin JG, Quitkin FM, McGrath PJ, Klein DF.  (1993)  Atypical depression.  In:  Dunner DL (Ed).  Current Psychiatric Therapy.  Philadelphia, PA:  WB Saunders.  pp 215-220. C 102  Klein DF.  (1993)  Foreword.  In:  Hollander E (Ed).  Obsessive Compulsive Related Disorders.  Washington, DC:  American Psychiatric Press, Inc.  pp xi-xvii. C 103  Klein DF.  (1993)  Panic may be a misfiring suffocation alarm.  In:  Montgomery SA (Ed).  Psychopharmacology of Panic.  New York City:  Oxford Medical Publications.  pp 67-73. C 104  Stewart JW, McGrath PJ, Quitkin FM, Klein DF.  (1993)  The treatment of atypical depression.  In:    The Proceedings of the International Committee for Prevention and Treatment of Depression (March 5-6, 1993). C 105  Klein DF.  (1993)  La physiologie et les troubles anxieux (Physiology and the anxiety disorders).  In:  Chneiweiss L, Albert E (Eds).  Stress Et Anxiete: Les Faux-Semblants,  Upjohn.  pp 93-114. C 106  Vieland VJ, Knowles JA, Fyer AJ, Stefanovich M, Freimer NF, Lish J, Adams P, Woodley K, Rassnick H, Heiman GA, White P, Das K, Klein DF, Ott J, Weissman MM, Gilliam TC.  (1994)  Linkage study of panic disorder:  A preliminary report.  In:  Gershon ES, Cloninger CR (Eds).  Genetic Approaches to Mental Disorders.  Washington, DC:   American Psychiatric Press, Inc.  pp 345-354. C 107 Laska EM, Klein DF, Lavori PW, Levine J, Robinson DS.  (1994)  Design issues for the clinical evaluation of psychotropic drugs.  In:  Prien RF, Robinson DS (Eds).  Clinical Evaluation of Psychotropic Drugs: Principles and Guideline.  New York:  Raven Press. C 108  Klein DF, Liebowitz MR, Gorman JM, Lewis CP.  (1994)  Evaluation of psychotropic drug treatment of panic-related disorders and social phobia.  In:  Prien RF, Robinson DS (Eds).  Clinical Evaluation of Psychotropic Drugs:  Principles and Guidelines.  New York:  Raven Press. C 109  Klein DF.  (1994)  Closing comments.  In:  Friedman S (Ed).  Anxiety Disorders in African Americans.   Springer Publishing Company.  pp 227-231. C 110  Klein DF, Schneier FR, Liebowitz MR.  (1994)  Novel therapeutic approaches to social phobia.  Current Therapeutic Approaches to Panic and Other Anxiety Disorders.  Basel, Switzerland:  S. Karger AG.  pp 187-191. C 111  Coplan JD, Wolk SI, Klein DF.  (1995)  Anxiety and the serotonin1A receptor.  In:  Bloom FE, Kupfer DJ (Eds).  Psychopharmacology:  The Fourth Generation of Progress.  New York:  Raven Press, Ltd.  pp 1301-1310. C 112  Stein DJ, Hollander E, Klein DF.  (1995)  Anxiodepression:  Evolution des Idees (Anxio-Depression: Evolution of Ideas).  In:  Olie JP, Poirier MF, Loo H (Eds).  Les Maladies Depressives (The Depressive Disorders).  Paris, France:  Flammarion.  pp 159-164. C 113  Glick ID, Lecrubier Y, Montgomery SA, Vinar O, Klein DF.  (1995)  Promising psychopharmacological agents available in Europe.  In:  Schatzberg AF, Nemeroff CB (Eds).  The American Psychiatric Press Textbook of Psychopharmacology.  Washington, DC:  American Psychiatric Press.  pp 839-846. C 114  Coplan JD, Klein DF.  (1996)  Pharmacological probes in panic disorder.  In:  Westenberg HGM, DenBoer H, Murphey D (Eds).  Advances in the Neurobiology of Anxiety Disorders.  Chichester, England:  John Wiley & Sons, Ltd.  pp 173-196. C 115  Rabkin JG, Stewart JW, Quitkin FM, McGrath PJ, Harrison WM, Klein DF.  (1996)  Should atypical depression be included in DSM-IV?  A review of the research evidence.  Prepared for the DSM-IV Committee on Affective Disorders.  In:  Widiger T (Ed).  APA Sourcebook, (Volume 2).   Washington, DC:  American Psychiatric Press, Inc.  pp 239-260. C 116  Klein DF.  (1996)  The development of nosological concepts in anxiety disorders.  In:  Ackenheil M, Bondy B, Engel R, Ermann M, Nedopil N (Eds).  Implications of Psychopharmacology to Psychiatry; Biological, Nosological, and Therapeutical Concepts.  Berlin & Heidelberg:  Springer Verlag.  pp 89-100. C 117  Schneier FS, Liebowitz MR, Beidel DC, Fyer AJ, George MS, Heimberg RG, Holt CS, Klein DF, Leven AP, Lydiard RB, Mannuzza S, Martin LY, Nardi AE, Terril DR, Spitzer RL, Turner SM, Uhde TW, Figueroa IV, Versiani M.  (1996)  Social Phobia.  In:  Widiger T (Ed).  APA Sourcebook, Volume 2.   Washington, DC:  American Psychiatric Press, Inc.  pp 507-548. C 118  Stewart J, Klein DF.  (1997)  Chronic (and Hysteroid) Dysphorias.  In: Akiskal HS, Cassano GB (Eds).  Dysthymia and the Spectrum of Chronic Depressions.  New York:   Guilford Press.  pp 174-182. C 119  Klein DF.  (1997)  Anxiety disorders.  In:  Breslau N, Roth T (Eds).  The Status of Research on Selected Mental Disorders: A Report to The Ethel and James Flinn Family Foundation.  Detroit, MI:  Henry Ford Health Sciences Center.  pp. 52-79. C 120  Klein DF, Hurowitz G.  (1998)  Irene: A case of bipolar disorder.  In:  Halgin RG, Whitbourne SK (Eds).  A Casebook in Abnormal Psychology; From the Files of Experts. New York City:  Oxford University Press.  pp 144-165. C 121  Preter M, Klein DF.  (1998)  Panic disorder and the suffocation false alarm theory: Current state of knowledge and further implications for neurobiologic theory testing.  In:  Bellodi L, Perna G (Eds).  International Workshop on the Panic-Respiration Connection.  Milan, Italy:  MDM Medical Media, SRL.  pp 1-24. C 122  Klein DF.  (1998)  Introduction.  In:  Sheffield A.  How You Can Survive When They’re Depressed - Living and Coping with Depression Fallout.  New York:  Harmony.  pp ix-xiii. C 123  Klein DF.  (1999)  Studying the respective contributions of pharmacotherapy and psychotherapy: Toward Collaborative Controlled Studies.  In:  Weissman S, Sabshin M, Eist H (Eds).  Psychiatry in the New Millenium.  Washington, DC:  American Psychiatric Press.  pp 217-235. C 124  Klein DF.  (1999)  A checklist for developing and reviewing comparative treatment evaluations in the areas of psychotherapy and pharmacotherapy.  In:  Janowsky DS (Ed). Psychotherapy Indications and Outcomes.  Washington, DC:  American Psychiatric Press, Inc.  pp 367-381. C 125  Marshall R, Klein DF.  (1999)  Diagnostic classification of anxiety disorders: Historical context and implications for neurobiology.  In:  Charney DS, Nestler EJ, Bunney BS (Eds).  Neurobiology of Mental Illness.  New York City:  Oxford University Press.  pp 437-450. C 126  Klein DF.  (1999)  The current utility and future development of algorithms.  In:  Fawcett J, Stein DJ, Jobson KO (Eds).  Textbook of Treatment Algorithms in Psychopharmacology.  Chichester, England:  John Wiley & Sons, Ltd.  pp 33-36. C 127  Klein DF.  (2001)  New ideas for testing treatments–What’s wrong and how to fix it.  In:  Weissman MM (Ed).  Treatment of Depression; Bridging the 21st Century.  Washington, DC:  American Psychiatric Press.  pp 197-211. C 128  Klein DF.  (2001)  Introduction.  In:  Griez EJL, Faravelli C, Nutt D, Zohar J (Eds).  The European Certificate Textbook of Anxiety Disorders.  Chichester, England:  John Wiley & Sons, Ltd.  pp xv-xxii. C 129129  Marshall RD, Klein DF.  (2003)  Conceptual Antecedents of the Anxiety Disorders.  In:  Nutt D, Ballinger J (Eds).  Anxiety Disorders.   Blackwell Publishing.  pp 3-22. C 130  Klein DF.  (2004)  Toughing it out.  In:  Spitzer R (Eds).  Treatment Companion to the DSM-IV-TR Casebook.  Washington, DC:  American Psychiatric Publishing, Inc.  pp 169-170 C 131  Klein D.  (2005)  Epilogue.  In:  Klein DF, Wender PH.  Understanding Depression, 2nd Edition.  New York City:  Oxford University Press.  pp 181-197. C 132  Klein D.  (2005)   Commentary:  “From metapsychology to molecular biology”.  In:  Kandel ER.  Psychiatry, Psychoanalysis, and the New Biology of Mind.  Washington, DC: American Psychiatric Publishing, Inc.  pp 107-113.